Apogee Biotechnology Corp is focused on the development of sphingosine kinase inhibitor for the treatment of solid tumors and a variety of chronic inflammatory diseases as well as in indications of damaging acute inflammation.In February 2007, Apogee Biotechnology moved into technology suites of the Hershey Center for Applied Research in Hummelstown, PA.In November 2020, the company received grants and contracts from NCI, BARDA, US Department of Defense and FDA Office of Orphan Products Development to develop opaganib.In August 2003, Apogee received two research grants from the National Cancer Institute to develop new drugs for the treatment of multiple forms of cancer. The grant will provide the company with $1 million during the next 2 years to investigate novel inhibitors of sphingosine kinase and human N-myristoyltransferase